STE insider transaction filings
STERIS plc — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-12. Screen STE transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Alegria Esther M. — Director | Grant/award (A): 1,506 (derivative) @ $0 · Grant/award (A): 512 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Boulud Pierre — Director | Grant/award (A): 1,025 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | FELDMANN CYNTHIA L — Director | Grant/award (A): 1,506 (derivative) @ $0 · Grant/award (A): 512 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | HOLLAND CHRISTOPHER S — Director | Grant/award (A): 1,025 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Martin Paul Edward — Director | Grant/award (A): 1,506 (derivative) @ $0 · Grant/award (A): 512 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Shah Nirav R — Director | Grant/award (A): 1,506 (derivative) @ $0 · Grant/award (A): 512 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Shapiro Louis — Director | Grant/award (A): 1,025 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Sohi Mohsen — Director | Option exercise (M): 4,058 @ $86.23 · Sale (S): 4,058 @ $235.78 · Grant/award (A): 1,099 (derivative) @ $0 · Grant/award (A): 1,229 (derivative) @ $0 · Option exercise (M): 4,058 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Sohi Mohsen — Director | Option exercise (M): 3,781 @ $71.40 · Tax withholding (F): 1,837 @ $212.30 · Option exercise (M): 3,781 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Zangerle John Adam — Sr. VP, Gen Counsel, and Sec. | Sale (S): 1,419 @ $209.28 | EDGAR |
| 2026-06-08 | 4 | Madsen Julia — Sr. VP and GM, Life Sciences | Tax withholding (F): 195 @ $212.24 | EDGAR |
| 2026-06-08 | 4 | Kohler Kenneth E — SVP & GM, AST | Tax withholding (F): 150 @ $212.24 | EDGAR |
| 2026-06-08 | 4 | Fraser Mary Clare — SVP & Chief HRO | Tax withholding (F): 600 @ $212.24 | EDGAR |
| 2026-06-08 | 4 | Tamaro Renato — V.P. & Corporate Treasurer | Tax withholding (F): 65 @ $212.24 | EDGAR |
| 2026-06-08 | 4 | Burton Karen L — Sr. Vice Pres., CFO | Tax withholding (F): 90 @ $212.24 | EDGAR |
| 2026-06-08 | 4 | Carestio Daniel A — President and CEO, Director | Tax withholding (F): 1,889 @ $212.24 · Sale (S): 3,054 @ $214.64 · Sale (S): 1,374 @ $212 | EDGAR |
| 2026-06-08 | 4 | Zangerle John Adam — Sr. VP, Gen Counsel, and Sec. | Tax withholding (F): 401 @ $212.24 | EDGAR |
| 2026-06-05 | 4 | Madsen Julia — Sr. VP and GM, Life Sciences | Tax withholding (F): 239 @ $210.19 | EDGAR |
| 2026-06-05 | 4 | Kohler Kenneth E — SVP & GM, AST | Tax withholding (F): 184 @ $210.19 | EDGAR |
| 2026-06-05 | 4 | Fraser Mary Clare — SVP & Chief HRO | Tax withholding (F): 311 @ $210.19 | EDGAR |
| 2026-06-05 | 4 | Tamaro Renato — V.P. & Corporate Treasurer | Tax withholding (F): 64 @ $210.19 | EDGAR |
| 2026-06-05 | 4 | Burton Karen L — Sr. Vice Pres., CFO | Tax withholding (F): 190 @ $210.19 | EDGAR |
| 2026-06-05 | 4 | Carestio Daniel A — President and CEO, Director | Tax withholding (F): 2,619 @ $210.19 | EDGAR |
| 2026-06-05 | 4 | Zangerle John Adam — Sr. VP, Gen Counsel, and Sec. | Tax withholding (F): 365 @ $210.19 | EDGAR |
| 2026-06-04 | 4 | McGowan Lindsey — VP, Chf. Comp. & Quality Offc. | Grant/award (A): 1,155 @ $0 · Tax withholding (F): 329 @ $209.76 · Grant/award (A): 4,036 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Majors Cary L — SVP and President, Healthcare | Grant/award (A): 4,746 @ $0 · Tax withholding (F): 67 @ $209.76 · Grant/award (A): 16,548 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Madsen Julia — Sr. VP and GM, Life Sciences | Grant/award (A): 2,316 @ $0 · Tax withholding (F): 127 @ $209.76 · Grant/award (A): 8,080 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Kohler Kenneth E — SVP & GM, AST | Grant/award (A): 2,199 @ $0 · Tax withholding (F): 66 @ $209.76 · Grant/award (A): 7,668 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Fraser Mary Clare — SVP & Chief HRO | Grant/award (A): 3,009 @ $0 · Tax withholding (F): 591 @ $209.76 · Grant/award (A): 10,492 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Boulud Pierre — Director | Grant/award (A): 367 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Tamaro Renato — V.P. & Corporate Treasurer | Grant/award (A): 750 @ $0 · Tax withholding (F): 41 @ $209.76 · Grant/award (A): 2,620 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Burton Karen L — Sr. Vice Pres., CFO | Grant/award (A): 5,325 @ $0 · Option exercise (M): 66 @ $209.76 · Grant/award (A): 18,564 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Carestio Daniel A — President and CEO, Director | Grant/award (A): 23,736 @ $0 · Tax withholding (F): 995 @ $209.76 · Grant/award (A): 82,740 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Zangerle John Adam — Sr. VP, Gen Counsel, and Sec. | Grant/award (A): 4,359 @ $0 · Tax withholding (F): 247 @ $209.76 · Grant/award (A): 15,200 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Breeden Richard C — Director | Option exercise (M): 3,781 @ $71.40 · Sale (S): 1,481 @ $209.51 · Option exercise (M): 3,781 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | McGowan Lindsey — VP, Chf. Comp. & Quality Offc. | Tax withholding (F): 198 @ $0 | EDGAR |
| 2026-06-03 | 4 | Majors Cary L — SVP and President, Healthcare | Tax withholding (F): 768 @ $0 | EDGAR |
| 2026-06-03 | 4 | Madsen Julia — Sr. VP and GM, Life Sciences | Tax withholding (F): 208 @ $0 | EDGAR |
| 2026-06-03 | 4 | Kohler Kenneth E — SVP & GM, AST | Tax withholding (F): 109 @ $0 | EDGAR |
| 2026-06-03 | 4 | Fraser Mary Clare — SVP & Chief HRO | Tax withholding (F): 673 @ $0 | EDGAR |
| 2026-06-03 | 4 | Tamaro Renato — V.P. & Corporate Treasurer | Tax withholding (F): 81 @ $0 | EDGAR |
| 2026-06-03 | 4 | Burton Karen L — Sr. Vice Pres., CFO | Tax withholding (F): 99 @ $0 | EDGAR |
| 2026-06-03 | 4 | Carestio Daniel A — President and CEO, Director | Tax withholding (F): 1,254 @ $0 | EDGAR |
| 2026-06-03 | 4 | Zangerle John Adam — Sr. VP, Gen Counsel, and Sec. | Tax withholding (F): 337 @ $0 | EDGAR |
| 2026-03-06 | 4 | FELDMANN CYNTHIA L — Director | Option exercise (M): 3,098 @ $152.32 · Sale (S): 3,098 @ $237.21 · Option exercise (M): 3,098 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | McGowan Lindsey — VP, Chf. Comp. & Quality Offc. | Grant/award (A): 798 @ $0 | EDGAR |
| 2025-11-25 | 4 | Madsen Julia — Sr. VP and GM, Life Sciences | Option exercise (M): 2,872 @ $114.22 · Sale (S): 2,872 @ $262 · Option exercise (M): 2,136 @ $147.05 · Sale (S): 2,136 @ $262 · Option exercise (M): 2,872 (derivative) @ $0 · Option exercise (M): 2,136 (derivative) @ $0 | EDGAR |
| 2025-11-20 | 4 | Tamaro Renato — V.P. & Corporate Treasurer | Option exercise (M): 3,536 @ $182.22 · Sale (S): 3,324 @ $257.43 · Sale (S): 212 @ $258.03 · Sale (S): 1,500 @ $257.76 · Option exercise (M): 3,536 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Zangerle John Adam — Sr. VP, Gen Counsel, and Sec. | Option exercise (M): 15,000 @ $69.72 · Sale (S): 15,000 @ $265.14 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Carestio Daniel A — President and CEO, Director | Sale (S): 159 @ $241.82 | EDGAR |
Recent 8-K events — STERIS plc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-08-06 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition ? 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=STE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →